Infectious Diseases News and Research

RSS

Study finds a lower compliance rate with recently released guidelines for COVID-19 care

Uptake of national guidelines for the treatment of children hospitalized with COVID-19 fell well below what would typically be expected, report researchers at the Medical University of South Carolina (MUSC) and elsewhere in Pediatrics.

17 Nov 2022

Could self-collected swabs play a role in the diagnosis and control of monkeypox?

In a recent study published in the journal Clinical Infectious Diseases, researchers evaluated the accuracy of patient-collected samples in diagnosing monkeypox virus infections.

16 Nov 2022

Study reveals neglected or late TB diagnoses related to COVID-19

In a recent study published in the journal BMJ Medicine, researchers modeled changing patterns in sex- and age-stratified new and relapse tuberculosis (TB) case notifications reported to the World Health Organization (WHO) for 45 nations with high TB, TB/human immunodeficiency virus (HIV) and multidrug-resistant TB (MDR-TB) burden between 2013 and 2019 due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

16 Nov 2022

Whole genome sequencing could help to reduce the spread of drug-resistant bacteria in hospitals

The spread of antibiotic-resistant bacteria in hospitals could be greatly reduced thanks to research by The University of Queensland and Queensland Health.

16 Nov 2022

Novel nasal vaccine approach induces potent lung immunity and protection against SARS-CoV-2

Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.

16 Nov 2022

Protein levels in lung tumors may predict prognosis, improve treatment and diagnostics

Lung cancer is the leading cause of cancer deaths globally and a top cause of cancer deaths in the Military Health System.

15 Nov 2022

What are the current challenges and future directions of mRNA nanomedicine?

Researchers presented challenges related to the clinical translation of messenger ribonucleic acid (mRNA) technology, recent innovations and future directions to improve the clinical efficacy of mRNA nanomedicine.

15 Nov 2022

Parasites associated with leprosy may have the ability to regenerate livers

Leprosy is one of the world's oldest and most persistent diseases but the bacteria that cause it may also have the surprising ability to grow and regenerate a vital organ.

15 Nov 2022

Alterations in vaginal microbiota among pregnant women with COVID-19 increase preterm birth risk

A new study conducted by researchers from Koç University İsbank Center for Infectious Diseases (KUISCID) reveals crucial data on the risk of preterm birth caused by the change in vaginal microbiota due to COVID 19.

11 Nov 2022

A knowledgebase of currently known categorized COVID-19 severity variants

In a recent study posted to the medRxiv* preprint server, researchers assessed human genome variants related to the susceptibility and severity of coronavirus disease 2019 (COVID-19).

10 Nov 2022

IVI and Lemonex sign MOU to join forces on vaccine development

The International Vaccine Institute announced on November 10 it signed a memorandum of understanding (MOU) with Lemonex, a company specializing in RNA gene therapy development, and agreed to seek cooperation in research and development.

10 Nov 2022

Global SARS-CoV-2 infection rates likely to be higher than previously reported

Serosurveillance provides estimates of antibody levels against infectious diseases and is considered the gold standard for measuring population immunity due to past infection or vaccination.

10 Nov 2022

Experimental therapeutic cancer vaccine leads to significant tumor regression in mice

An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to significant tumor regression in mice, report investigators from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

10 Nov 2022

Researchers demonstrate that neutralizing antibody titers wane over time in ChAdOx1, BNT162b2 and mRNA-1273 vaccinees

Researchers investigated the neutralization antibody titers and the efficacy of the humoral and cellular immunities in individuals vaccinated with three COVID-19 vaccines.

10 Nov 2022

Study highlights major disparities in geographical access to COVID-19 "Test to Treat" sites

A new study from investigators at Brigham and Women's Hospital, a founding member of Mass General Brigham, the University of Virginia School of Medicine, and the University of Pittsburgh, finds that COVID-19 "Test to Treat" sites - clinical centers launched based on a federal initiative to provide free testing, diagnosis, and immediate access to COVID-19 antiviral treatment with Paxlovid - may not be accessible to those who need it most.

9 Nov 2022

New tool maps how breast cancer grows in previously unseen detail

New technology can trace which populations of breast cancer cells are responsible for the spread of the disease, and for the first time highlights how the location of cancer cells could be as important as mutations in tumor growth.

9 Nov 2022

Immunological responses against monkeypox virus concerning the 2022 outbreak

A new study aimed to analyze the kinetics of the pox-specific T-cell induction, the inflammatory profile, and the inflammatory profile in human cases of the current monkeypox outbreak.

9 Nov 2022

The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest SARS-CoV-2 antigens for the newly designated Omicron BA.5 variant.

From The Native Antigen Company 7 Nov 2022

Study shows likely SARS-CoV-2 transmission between different rooms of a quarantine hotel

The results of this study, published in the Emerging Infectious Diseases journal, underline the enhanced transmissibility of the Omicron variants of the virus, which takes advantage of small airstreams to jump to new hosts. "Our findings emphasize the importance of ventilation and integrity of building structure in quarantine facilities."

6 Nov 2022

Study finds no evidence of major SARS-CoV-2 spread among wild rodents

A new study published in the Emerging Infectious Diseases journal conducted a large-scale serologic survey of SARS-CoV-2 in multiple rodent species to determine the reverse transmission of SARS-Cov-2 and its establishment in wild rodents across different settings.

6 Nov 2022

Infectious Diseases News and Research

Study finds a lower compliance rate with recently released guidelines for COVID-19 care

Could self-collected swabs play a role in the diagnosis and control of monkeypox?

Study reveals neglected or late TB diagnoses related to COVID-19

Whole genome sequencing could help to reduce the spread of drug-resistant bacteria in hospitals

Novel nasal vaccine approach induces potent lung immunity and protection against SARS-CoV-2

Protein levels in lung tumors may predict prognosis, improve treatment and diagnostics

What are the current challenges and future directions of mRNA nanomedicine?

Parasites associated with leprosy may have the ability to regenerate livers

Alterations in vaginal microbiota among pregnant women with COVID-19 increase preterm birth risk

A knowledgebase of currently known categorized COVID-19 severity variants

IVI and Lemonex sign MOU to join forces on vaccine development

Global SARS-CoV-2 infection rates likely to be higher than previously reported

Experimental therapeutic cancer vaccine leads to significant tumor regression in mice

Researchers demonstrate that neutralizing antibody titers wane over time in ChAdOx1, BNT162b2 and mRNA-1273 vaccinees

Study highlights major disparities in geographical access to COVID-19 "Test to Treat" sites

New tool maps how breast cancer grows in previously unseen detail

Immunological responses against monkeypox virus concerning the 2022 outbreak

The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant

Study shows likely SARS-CoV-2 transmission between different rooms of a quarantine hotel

Study finds no evidence of major SARS-CoV-2 spread among wild rodents

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News